Evidence map›Paper›PMID 27421919›Full record

ArticlePsycho-oncology2017

Group-based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancers.

Sharon L Manne, Shannon Myers-Virtue, David Kissane, Melissa L Ozga, Deborah A Kashy, Stephen C Rubin, Norman G Rosenblum, Carolyn J Heckman

Abstract read
In one paragraph

Article in Psycho-oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Predicting psychological distress in advanced ovarian cancer patients during the COVID-19 pandemic.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Change in worry over time among Hispanic women with thyroid cancer.Journal of cancer survivorship : research and practice · 2022
    Article
  13. Individual courses and determinants of fear of cancer recurrence in long-term breast cancer survivors with and without recurrence.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  14. Article
  15. Longitudinal course and predictors of communication and affect management self-efficacy among women newly diagnosed with gynecological cancers.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sharon L ManneRutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Shannon Myers-VirtueTemple University Maurice H. Kornberg School of Dentistry, Philadelphia, Pennsylvania, USA.
David KissaneMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Melissa L OzgaMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Deborah A KashyMichigan State University, East Lansing, Michigan, USA.
Stephen C RubinFox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Norman G RosenblumThomas Jefferson University, Philadelphia, Pennsylvania, USA.
Carolyn J HeckmanFox Chase Cancer Center, Philadelphia, Pennsylvania, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
PSYCHOLOGICAL INTERVENTION FOR OVARIAN CANCER PATIENTSR01CA085566 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI MANNE, SHARON L · 2000 to 2014
$4.8M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA085566
6 · The paper itself

Abstract

objectiveFear of cancer recurrence is an important clinical phenomenon and is associated with decrements in life domains. The study goals were to characterize patterns of global fear of recurrence (FOR) and 4 domains of fear (health, role, womanhood, and death worry) over time in women who were diagnosed with gynecological cancer and to identify demographic, medical, and psychological predictors of FOR.

methodOne hundred eighteen women participating in the usual care arm of a randomized trial completed the Concerns about Recurrence scale as well as measures of depressive symptoms, cancer-specific distress, coping, coping efficacy, and social network responses at 4 time points. The majority of the sample was diagnosed with stage 3 ovarian cancer.

resultsGroup-based trajectory modeling identified subgroups of women with high-stable (49.1%), high-decreasing (25.3%), and low-stable (25.5%) trajectories for global FOR. For role worries, 3 similar group trajectories were identified. For health worries, modeling identified subgroups with high-decreasing (19.1%) and low-increasing (80.9%) trajectories. For womanhood worries, modeling identified subgroups with high-increasing (15.7%) and low-decreasing (84.2%) trajectories. Young age, metastatic cancer, depression, cancer distress, holding back, and lower coping efficacy were associated with the high-stable global FOR and at least 1 domain of FOR.

conclusionAlmost half of the women recently diagnosed with gynecological cancer evidence persistently elevated FOR over the 6-month period postdiagnosis. Psychological interventions to reduce FOR may be more effective if they focus on teaching patients coping skills, as well as greater comfort expressing cancer-specific concerns to others.

Indexed as

Adaptation, PsychologicalAdultAgedAnxietyCarcinoma, Ovarian EpithelialDepressionDepressive DisorderFearFemaleGenital Neoplasms, FemaleHumansMiddle AgedNeoplasm Recurrence, LocalNeoplasms, Glandular and EpithelialOvarian NeoplasmsQuality of Lifecoping with canceremotional expressivitygynecological cancerpsychological adaptationrecurrence fear

Identifiers

PMID27421919
PMCPMC5507742

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.